1
Results: Non-Hispanic blacks had roughly double the risk of underdiagnosis as non-Hispanic whites.
2
Conclusions: IBD disease burden is lower in ethnic minorities compared to Non-Hispanic Whites.
3
Comparisons were made between African Americans, Caribbean blacks, Caribbean Hispanics, and non-Hispanic whites.
4
More than two-thirds are men and nearly all are non-Hispanic whites.
5
Odds ratios were estimated for non-Hispanic whites and several ethnic subgroups using 2-sided tests.
6
Eleven had data on A1C for African Americans and non-Hispanic whites and met selection criteria.
7
Conclusions: Fasting insulin level and blood pressure were positively associated among African-Americans and non-Hispanic whites.
8
To avoid ethnic confounding, all subjects were non-Hispanic whites.
9
The suicide rate rose 40 percent for non-Hispanic whites.
10
We also sought to determine whether risk factors for retinopathy vary between Hispanics and non-Hispanic whites.
11
The numbers were almost reversed for non-Hispanic whites.
12
African American and Hispanic patients are more likely to present with associated PAH compared to non-Hispanic whites.
13
The Census projects that non-Hispanic Whites will no longer be a majority of the population in 2045.
14
When the researchers adjusted for socioeconomic factors, the risk difference between U.S.-born Hispanics and non-Hispanic whites disappeared.
15
Selected API groups had less favorable distributions of stage at diagnosis for certain cancers than non-Hispanic whites.
16
Non-Hispanic Blacks without T2D received significantly lower HEI-2010 scores than non-Hispanic Whites.
